BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23745319)

  • 1. Cognitive enhancement effects of Bacopa monnieri (Brahmi) on novel object recognition and VGLUT1 density in the prefrontal cortex, striatum, and hippocampus of sub-chronic phencyclidine rat model of schizophrenia.
    Piyabhan P; Wetchateng T
    J Med Assoc Thai; 2013 May; 96(5):625-32. PubMed ID: 23745319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive enhancement effects of Bacopa monnieri (Brahmi) on novel object recognition and NMDA receptor immunodensity in the prefrontal cortex and hippocampus of sub-chronic phencyclidine rat model of schizophrenia.
    Piyabhan P; Wetchateng T; Sireeratawong S
    J Med Assoc Thai; 2013 Feb; 96(2):231-8. PubMed ID: 23936991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacopa monnieri (Brahmi) Prevents Cognitive Deficit by Maintaining CA2/3 VGLUT1 Density of Sub-Chronic Phencyclidine Rat Model of Schizophrenia in Normal Level.
    Piyabhan P; Wetchateng T
    J Med Assoc Thai; 2016 Jul; 99 Suppl 4():S222-9. PubMed ID: 29926716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacopa monnieri (Brahmi) Enhanced Cognitive Function and Prevented Cognitive Impairment by Increasing VGLUT2 Immunodensity in Prefrontal Cortex of Sub-Chronic Phencyclidine Rat Model of Schizophrenia.
    Piyabhan P; Wetchateng T
    J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S7-15. PubMed ID: 26387382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of Bacopa monnieri (Brahmi) on novel object recognition and NMDAR1 immunodensity in the prefrontal cortex, striatum and hippocampus of sub-chronic phencyclidine rat model of schizophrenia.
    Piyabhan P; Wetchateng T
    J Med Assoc Thai; 2014 Aug; 97 Suppl 8():S50-5. PubMed ID: 25518293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacopa monnieri (Brahmi) improved novel object recognition task and increased cerebral vesicular glutamate transporter type 3 in sub-chronic phencyclidine rat model of schizophrenia.
    Piyabhan P; Wannasiri S; Naowaboot J
    Clin Exp Pharmacol Physiol; 2016 Dec; 43(12):1234-1242. PubMed ID: 27562725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive enhancement effects of Bacopa monnieri (Brahmi) on novel object recognition and neuronal density in the prefrontal cortex, striatum and hippocampus in sub-chronic phencyclidine administration rat model of schizophrenia.
    Wetchateng T; Piyabhan P
    J Med Assoc Thai; 2015 Mar; 98 Suppl 2():S56-63. PubMed ID: 26211105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pre- and post-treatment with
    Piyabhan P; Tingpej P; Duansak N
    Neuropsychiatr Dis Treat; 2019; 15():1103-1117. PubMed ID: 31118643
    [No Abstract]   [Full Text] [Related]  

  • 9. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.
    Abdul-Monim Z; Neill JC; Reynolds GP
    J Psychopharmacol; 2007 Mar; 21(2):198-205. PubMed ID: 17329300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.
    Grayson B; Idris NF; Neill JC
    Behav Brain Res; 2007 Nov; 184(1):31-8. PubMed ID: 17675172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance.
    Pedersen CS; Goetghebeur P; Dias R
    J Neurosci Methods; 2009 Dec; 185(1):66-9. PubMed ID: 19761795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm.
    Abdul-Monim Z; Reynolds GP; Neill JC
    Behav Brain Res; 2006 May; 169(2):263-73. PubMed ID: 16500717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia.
    Vigano D; Guidali C; Petrosino S; Realini N; Rubino T; Di Marzo V; Parolaro D
    Int J Neuropsychopharmacol; 2009 Jun; 12(5):599-614. PubMed ID: 18789179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol attenuates the cognitive deficits in the novel object recognition task induced by sub-chronic phencyclidine in ovariectomized rats.
    Roseman AS; McGregor C; Thornton JE
    Behav Brain Res; 2012 Jul; 233(1):105-12. PubMed ID: 22561127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia.
    McLean SL; Idris NF; Woolley ML; Neill JC
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):440-50. PubMed ID: 19268547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer's disease model.
    Uabundit N; Wattanathorn J; Mucimapura S; Ingkaninan K
    J Ethnopharmacol; 2010 Jan; 127(1):26-31. PubMed ID: 19808086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease.
    Kashani A; Lepicard E; Poirel O; Videau C; David JP; Fallet-Bianco C; Simon A; Delacourte A; Giros B; Epelbaum J; Betancur C; El Mestikawy S
    Neurobiol Aging; 2008 Nov; 29(11):1619-30. PubMed ID: 17531353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia.
    Zavitsanou K; Nguyen V; Newell K; Ballantyne P; Huang XF
    J Chem Neuroanat; 2008 Oct; 36(2):71-6. PubMed ID: 18640263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats.
    McLean SL; Idris NF; Grayson B; Gendle DF; Mackie C; Lesage AS; Pemberton DJ; Neill JC
    J Psychopharmacol; 2012 Sep; 26(9):1265-70. PubMed ID: 22182741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
    Nabeshima T; Mouri A; Murai R; Noda Y
    Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.